The Medical Advisor

Cardiovascular-Kidney-Metabolic (CKM) syndrome is a newly recognized health condition defined by the American Heart Association (AHA) in 2023 . It describes the strong interconnections among heart disease, kidney disease, type 2 diabetes, and obesity. These conditions often overlap and worsen each other, creating a cycle that significantly increases the risk of serious complications like heart attacks, strokes, heart failure, and kidney failure. As of 2025, CKM syndrome affects a staggering portion of the population: nearly 90% of U.S. adults have at least stage 1 or higher, with about 15% in advanced stages (3 or 4). Globally, similar patterns are emerging, highlighting the need for integrated prevention and management. Why CKM Syndrome Matters Traditionally, heart disease, kidney disease, and metabolic conditions like diabetes and obesity were treated separately. The AHA's CKM framework shifts this to a holistic approach, recognizing that poor health in one area accelerates prob...

Dr. Thomas N. Seyfried, PhD, Professor of Biology at Boston College, has been singing the praises of an ancestral diet for treating the modern disease of cancer for years… and with good reason. His theory that cancer is a metabolic disease sounds almost too simplistic, and yet makes perfect sense when you understand what drives cancer’s growth. Standard of Care: The Cut, Poison and Burn Method and Its Miserable Success Record Seyfried is not a fan of conventional medical cancer treatments. As he states in his groundbreaking book, Cancer as a Metabolic Disease: On the Origin, Management, and Prevention of Cancer, the majority of today’s health care practitioners are required to prescribe conventional cancer treatments like chemotherapy and radiation—despite their toxicity and the possibility that they encourage new tumor growth. In fact, if a physician does not include these modalities in a treatment plan, the physician may be at risk of losing his medical ...